EuroSCORE II
European System for Cardiac Operative Risk Evaluation II. Estimates operative mortality risk for adult cardiac surgery. Updated model from EuroSCORE I with improved calibration.
Score interpretation
→ EuroSCORE II Low Risk: Predicted mortality <2%. Proceed with standard cardiac surgery protocol. Routine ICU monitoring post-op.
→ EuroSCORE II Moderate Risk: Predicted mortality 2–5%. Discuss risk/benefit with patient and family. Senior cardiac anaesthesia and surgical team. CICU level care post-op.
→ EuroSCORE II High Risk: Predicted mortality >5%. Multi-disciplinary heart team review essential. Consider alternative interventions (TAVI, CABG vs PCI). Obtain written informed consent detailing mortality risk.
Interpretation bands for the EuroSCORE II. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Protamine Sulphate (Heparin Reversal) · Heparin Reversal / Cardiac Surgery
- Aprotinin · Antifibrinolytic — Cardiac Surgery
- Protamine Sulphate · Heparin Antidote — Vascular / Cardiac Surgery
- Tranexamic Acid (ICU/Trauma/Surgical) · Antifibrinolytic
- Lidocaine IV (Cardiac Arrhythmia) · Antiarrhythmic
- Mavacamten · Cardiac myosin inhibitor
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.